Best Anti-Anxiety Medication
Selective serotonin reuptake inhibitors (SSRIs), specifically escitalopram or sertraline, are the best first-line anti-anxiety medications for adults.
First-Line Pharmacotherapy
The evidence consistently supports SSRIs as the optimal initial pharmacologic treatment across anxiety disorders 1, 2. Among SSRIs, escitalopram and sertraline stand out as the preferred agents based on international guideline consensus 1.
Why These Two Specifically:
- Escitalopram demonstrated superior efficacy in network meta-analysis with the greatest reduction in anxiety symptoms (weighted mean difference -3.2 on Hamilton Anxiety Scale) 3
- Sertraline is consistently listed as first-line by NICE, German S3, and Canadian guidelines due to favorable tolerability and lower discontinuation symptoms 1
- Both have robust evidence from 26 RCTs supporting SSRI use in anxiety disorders 1
Alternative First-Line SSRIs:
- Paroxetine - equally effective but relegated to second-line by some guidelines due to more discontinuation symptoms 1
- Fluvoxamine - also effective but similar tolerability concerns 1
Second-Line Options
If SSRIs fail or are not tolerated:
SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors):
- Venlafaxine is the primary SNRI recommended, supported by 5 RCTs 1, 2
- Duloxetine showed excellent efficacy in head-to-head comparisons 3
Other alternatives:
What to Avoid
Benzodiazepines are NOT recommended for routine use despite their rapid anxiolytic effects, due to addiction potential and lack of long-term benefit 4, 5. They may be considered second-line only for specific situations (alprazolam, bromazepam, clonazepam per Canadian guidelines) 1.
Explicitly not recommended:
- Beta-blockers (atenolol, propranolol) - negative evidence 1
- Antipsychotics like quetiapine - insufficient evidence 1
- Tricyclic antidepressants like imipramine - inferior tolerability 1
Treatment Duration
Continue medication for 6-12 months after remission to prevent relapse 4, 5. When discontinuing, use slow tapering (>4 weeks) plus psychological support rather than abrupt cessation, as this reduces relapse risk significantly (RR 0.52) 6.
Critical Implementation Points
Start with escitalopram 10-20mg daily or sertraline 50-200mg daily. Monitor response over 4-8 weeks. If inadequate response, switch to another SSRI or move to venlafaxine rather than adding benzodiazepines 1, 2.
Common pitfall: Stopping medication too early after symptom improvement. The 6-12 month continuation is essential for sustained remission 4, 5.
Optimal approach: Combine SSRI/SNRI with cognitive behavioral therapy (CBT) when available, though medication alone is effective 1, 2. The combination may provide superior long-term quality of life outcomes, particularly through sustained reduction in depressive symptoms 7.